Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Chimeron Bio logo — Redefining genetic medicine with future-forward RNA technolo...

Chimeron Bio

Redefining genetic medicine with future-forward RNA technology designed to deliver meaningful patient results.

Founded 2015 United States Philadelphia, United States 12 employees Angel Total: $1.15M Biotechnology, Health Care +1

General Information

Company Name Chimeron Bio
Founded Year 2015
Location United States Philadelphia, United States
Founders / Decision Makers
Team member
Employees 12
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Angel
Social

BounceWatch is an independent company data service, not affiliated with Chimeron Bio. To contact Chimeron Bio, visit chimeronbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Chimeron Bio

Chimeron Bio is a biotech company founded in 2015 with a focus on developing personalized gene therapies, starting with cancer. The company's slogan "Combining our first-in-class platform & the science of synthetic genomics to transform RNA therapy" reflects their commitment to leveraging cutting-edge technology in the field of biotechnology and healthcare. Based in the United States, Chimeron Bio recently secured a significant $300.00K in an Angel Round investment on 24 December 2020. This infusion of capital demonstrates the growing interest in the potential of their pioneering platform, sparking anticipation for advancements in the field of RNA therapy. With a clear focus on individualized treatments, Chimeron Bio has positioned itself as a promising player in the biotech industry, poised to make substantial contributions to the future of healthcare.

Taxonomy: biotech, synthetic genomics, RNA therapy, personalized gene therapies, cancer treatment, genetic engineering, biomedical technology, precision medicine, pharmaceuticals, innovation, biomedical research, startup, investment, science

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Angel Round $300.00K -
24 Dec 2020
Venture Round Undisclosed 1
Dreavent Capital
01 Jan 2018
Seed Round $845.00K -
01 Jul 2016

Chimeron Bio Alternatives & Competitors

View All Alternatives
Chimeron Bio vs
Function
Function United States

Personalized functional genomics transforming the future of cancer

Series A
7 employees
Biotechnology, Health and Wellness
Chimeron Bio vs
AAVantgarde Bio
AAVantgarde Bio Italy

Delivering the next generation gene therapies

Series A
19 employees
Biotechnology, Health Care
Chimeron Bio vs
Fore Biotherapeutics
Fore Biotherapeutics United States

A precision oncology company rooted in science and innovation, developing cancer therapies guided by...

Series D
46 employees
Biotechnology, Health Care
View all alternatives

FAQ About Chimeron Bio

Redefining genetic medicine with future-forward RNA technology designed to deliver meaningful patient results.
Chimeron Bio was founded in 2015.
Chimeron Bio is headquartered in Philadelphia, United States.
Chimeron Bio operates in Biotechnology, Health Care and Health and Wellness. Its work centres on biotech, synthetic genomics, RNA therapy and personalized gene therapies.
Chimeron Bio has approximately 12 employees.
Chimeron Bio has completed 3 funding rounds, raising a total of $1.15M. The latest funding stage is Angel.
Top alternatives and competitors to Chimeron Bio include Function, AAVantgarde Bio, Fore Biotherapeutics, PMV Pharmaceuticals, Inc., Phlox Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Chimeron Bio and Function are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Chimeron Bio, https://bouncewatch.com/company/chimeron-bio, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes